News | News By Subject | News by Disease News By Date | Search News

Multiple myeloma News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Roche (RHHBY) Slammed With Partial Holds for Two Combo Cancer Trials     9/20/2017
FDA Orders 6 Partial or Full Clinical Holds on Celgene (CELG)'s Blood Cancer Studies     9/8/2017
Patient Deaths Prompt the FDA to Suspend Three of Merck & Co. (MRK)'s Keytruda Trials     7/7/2017
Deaths Force Merck & Co. (MRK) to Halt Enrollment for Blood Cancer Studies     6/14/2017
Unknown Nanjing Legend Emerges as a CAR-T Phenom at ASCO     6/7/2017
Investors Sigh With Relief as bluebird bio (BLUE), Celgene (CELG)'s CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free     6/5/2017
This Drug Could be Johnson & Johnson (JNJ)'s Next Billion-Dollar Blockbuster     1/30/2017
bluebird bio (BLUE), Celgene (CELG)'s Multiple Myeloma CAR-T Drug Shines in Tiny Study     12/2/2016
The History Between a Biogen (BIIB) Drug and a High-Profile Democratic Party Fundraiser     10/17/2016
Karyopharm (KPTI) Touts Mid-Stage Data, May See Quicker Approval of Multiple Myeloma Drug     9/6/2016
3 Biotechs Expecting to Release Clinical Trial Data Soon     9/1/2016
Genmab, Inc. (GEN.CO), Johnson & Johnson (JNJ)'s Daratumumab Granted Breakthrough Tag by the FDA     7/26/2016
Amgen (AMGN) Flinches Over Meeting to Review Cost of Multiple Myeloma Drugs     4/7/2016
Janssen Research & Development, Genentech (RHHBY) Forge Clinical Trials Agreement     3/23/2016
Three Drugs Could Catapult Three Big Pharma Revenues This Year     2/9/2016

News from Around the Web
Amgen (AMGN)’s Backup Plan For Kyprolis Flop     9/30/2016
American Society of Hematology: Secondary Cancers Cloud Myeloma Drug, Roswell Park Cancer Institute Study     12/10/2010
High Response Rates Seen In Phase-III Trial Of Chemotherapy, New Drug And Stem Cells In Myeloma, Azienda Ospedaliera Universitaria San Giovanni Battista of Torino Study     10/14/2010
Possible Genetic Links Between Environmental Toxins And Multiple Myeloma, Bank on a Cure(R) Study     8/14/2009
Treatment With Anti-anemia Drugs May Not Be Safe For Multiple Myeloma Patients, American Journal of Hematology     8/15/2008
One Gene May Be Key to Myeloma, National Cancer Institute Researchers Find     6/24/2008
Blocking a Single Protein Proves Toxic to Myeloma Cells in National Institutes of Health (NIH) Studies     6/23/2008
Three-Drug Combination "Extremely Promising" As First-Line Therapy for Multiple Myeloma, Researchers Say     12/14/2007
New Therapeutic Options for Newly Diagnosed Multiple Myeloma Patients     12/11/2007
Mayo Clinic: Multiple Myeloma Clinical Trial Shows Distinct Survival Benefit with Lower Dose of Steroids     12/10/2007
ZOLINZA (vorinostat) in Combination with Bortezomib Demonstrated Clinical Activity     12/10/2007
Gene Profiling Can Single Out the Worst Cases of Multiple Myeloma and Guide Therapy     9/19/2007
Emory University Researchers Identify Signaling Protein for Multiple Myeloma     9/11/2007
Potential Therapeutic Targets Identified in Multiple Myeloma     8/14/2007
Mayo Clinic Cancer Center Researcher Finds Mold By-product Kills Multiple Myeloma     4/16/2007

Press Releases
Autolus Announces First-Dose Cohort Completed In APRIL Study Of AUTO2: A Phase I/II Study In Patients With Multiple Myeloma     9/18/2017
SELLAS Life Sci' Galinpepimut-S Induces Specific, Robust And Durable Immune Responses In Patients With High-Risk Multiple Myeloma - Correlated With Clinical Benefit     9/14/2017
Array BioPharma (ARRY) Release: Phase III COLUMBUS Part 2 Results In BRAF-Mutant Melanoma Presented At European Society For Medical Oncology Congress     9/11/2017
Poseida Therapeutics Presents Novel BCMA-Specific CAR-T Therapy At CAR-TCR Summit     9/6/2017
Genmab A/S (GEN.CO) Announces Positive Topline Results In Phase III ALCYONE Study Of Daratumumab In Front Line Multiple Myeloma     8/24/2017
Unum Announces Active Investigational New Drug (IND) Application For ACTR087 In Combination With SEA-BCMA In Patients With Relapsed/Refractory Multiple Myeloma     8/23/2017
PharmaMar Starts A Quadruple Combination Study With Aplidin For The Treatment Of Multiple Myeloma     8/9/2017
Kite Pharma (KITE) Files Key FDA Filing for KITE-585     8/8/2017
New Evidence Of Sutro Biopharma ADC's Potency In Human Tumor Xenografts     7/17/2017
Amgen (AMGN) Release: Second Phase III Study Shows Kyprolis (Carfilzomib) Regimen Significantly Improves Overall Survival In Patients With Relapsed Multiple Myeloma     7/13/2017
Data Presentations At European Hematology Association 22nd Annual Congress Further Validate SkylineDx Prognostic Tools In Multiple Myeloma     6/20/2017
Janssen Biotech (JNJ) Release: DARZALEX (daratumumab) Approved By The U.S. FDA In Combination With Pomalidomide And Dexamethasone For Patients With Multiple Myeloma Who Have Received At Least Two Prior Therapies     6/19/2017
FDA Accepts Amgen (AMGN)'s Supplemental Biologics License Application To Expand Indication For XGEVA (Denosumab) To Include Multiple Myeloma Patients     6/19/2017
Merck & Co. (MRK) Provides Update On Multiple Myeloma Studies KEYNOTE-183 And 185 Of KEYTRUDA (Pembrolizumab) In Combination With Other Therapies     6/13/2017
Affimed (AFMD) Presents Data On First-In-Class BCMA-Targeting Immune Cell Engager AFM26 At ASCO Annual Meeting 2017     6/6/2017

//-->